pharmaphorum

ASH: Jaypirca matches Imbruvica in first-line CLL trial

The reversible BTK inhibitor was at least as effective as AbbVie/Johnson & Johnson's older, non-reversible drug Imbruvica ...

Scientists develop mini human heart organoid that mimics atrial fibrillation

Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast ...
Fierce Pharma

Milestone wins first-ever FDA approval with green light for heart arrhythmia nasal spray

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given ...
News-Medical.Net on MSN

Human heart organoids enable new therapies for atrial fibrillation

Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast ...

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (…

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...